Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-15-003760
Filing Date
2015-08-13
Accepted
2015-08-13 09:41:21
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cbmg_10q.htm 10-Q 1572663
2 CERTIFICATION cbmg_ex311.htm EX-31.1 17186
3 CERTIFICATION cbmg_ex312.htm EX-31.2 17156
4 CERTIFICATION cbmg_ex321.htm EX-32.1 10650
  Complete submission text file 0001354488-15-003760.txt   4853210

Data Files

Seq Description Document Type Size
5 cmbg-20150630.xml EX-101.INS 702842
6 cmbg-20150630.xsd EX-101.SCH 51548
7 cmbg-20150630_cal.xml EX-101.CAL 60058
8 cmbg-20150630_def.xml EX-101.DEF 101232
9 cmbg-20150630_lab.xml EX-101.LAB 336450
10 cmbg-20150630_pre.xml EX-101.PRE 248277
Mailing Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301
Business Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301 (650) 566-5064
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36498 | Film No.: 151049008
SIC: 2836 Biological Products, (No Diagnostic Substances)